Bellerophon Therapeutics, Inc.
BLPH
BLPH was delisted on the 13th of October, 2023.
22 hedge funds and large institutions have $3.82M invested in Bellerophon Therapeutics, Inc. in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 5 closing their positions.
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
0% more funds holding
Funds holding: 22 → 22 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
20% less capital invested
Capital invested by funds: $4.81M → $3.82M (-$986K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$246K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$96.6K |
| 3 |
Millennium Management
New York
|
+$80.1K |
| 4 |
TI
Telemetry Investments
New York
|
+$57.4K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$37.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$166K |
| 2 |
ACM
ACT Capital Management
Wayne,
Pennsylvania
|
-$102K |
| 3 |
Renaissance Technologies
New York
|
-$75.7K |
| 4 |
HF
HRT Financial
New York
|
-$48K |
| 5 |
Rockefeller Capital Management
New York
|
-$22K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| – | +$53 | +16 | +22% |
|
BLPH Hedge Fund Activity: Q4 2021 in Review
22 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Bellerophon Therapeutics, Inc. (BLPH) for Q4 2021, worth a combined $3.82M — down 20% from $4.81M a quarter earlier.
Fund positioning in BLPH was balanced in Q4 2021: 5 funds opened new positions, 5 closed out, 7 added to existing stakes and 4 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $246K. The largest seller was Wells Fargo, cutting an estimated $166K.
- 22 institutional investors held Bellerophon Therapeutics, Inc. (BLPH) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $3.82M of Bellerophon Therapeutics, Inc. stock for Q4 2021, down 20% quarter-over-quarter.
- 5 funds opened new Bellerophon Therapeutics, Inc. positions in Q4 2021 and 5 closed out, a net change of 0 holders.
- The largest Bellerophon Therapeutics, Inc. buyer in Q4 2021 was Jane Street, an estimated $246K added.
- The largest Bellerophon Therapeutics, Inc. seller in Q4 2021 was Wells Fargo, an estimated $166K sold.
Based on aggregated 13F filings for Q4 2021.